MiR-196b-5p is dysregulated in many malignancies, has been related to cancer prognosis, and targets c-myc, ERG, MEIS1, FAS, ABL1, BCL-2 and several HOX genes (Table S2 in File S1). This evidence concerns the gene MEIS1 and cancer.